These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 29623390)

  • 1. The role of genetics and epigenetics in rheumatic diseases: are they really a target to be aimed at?
    Kato M; Yasuda S; Atsumi T
    Rheumatol Int; 2018 Aug; 38(8):1333-1338. PubMed ID: 29623390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Biological therapy of arthritis and systemic autoimmune diseases].
    Tamási L; Szekanecz Z
    Orv Hetil; 2007 Apr; 148 Suppl 1():63-70. PubMed ID: 17430797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The comparative one-year performance of anti-tumor necrosis factor alpha drugs in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: results from a longitudinal, observational, multicenter study.
    Heiberg MS; Koldingsnes W; Mikkelsen K; Rødevand E; Kaufmann C; Mowinckel P; Kvien TK
    Arthritis Rheum; 2008 Feb; 59(2):234-40. PubMed ID: 18240258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biologic Therapies for Autoimmune and Connective Tissue Diseases.
    Wolfe RM; Ang DC
    Immunol Allergy Clin North Am; 2017 May; 37(2):283-299. PubMed ID: 28366477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative analysis of anxiety-depressive spectrum disorders in patients with rheumatic diseases.
    Lisitsyna TA; Veltishchev DY; Seravina OF; Kovalevskaya OB; Starovoytova MN; Desinova OV; Abramkin AA; Ovcharov PS; Vasil'ev VI; Alekberova ZS; Krasnov VN; Nasonov EL
    Ter Arkh; 2018 May; 90(5):30-37. PubMed ID: 30701894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The -308 tumour necrosis factor-alpha gene polymorphism predicts therapeutic response to TNFalpha-blockers in rheumatoid arthritis and spondyloarthritis patients.
    Seitz M; Wirthmüller U; Möller B; Villiger PM
    Rheumatology (Oxford); 2007 Jan; 46(1):93-6. PubMed ID: 16720636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumour necrosis factor polymorphisms in rheumatic diseases.
    Field M
    QJM; 2001 May; 94(5):237-46. PubMed ID: 11353097
    [No Abstract]   [Full Text] [Related]  

  • 8. Epigenetics of inflammatory arthritis.
    Hammaker D; Firestein GS
    Curr Opin Rheumatol; 2018 Mar; 30(2):188-196. PubMed ID: 29194108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetics, environment, and gene-environment interactions in the development of systemic rheumatic diseases.
    Sparks JA; Costenbader KH
    Rheum Dis Clin North Am; 2014 Nov; 40(4):637-57. PubMed ID: 25437282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA genes and predisposition to rheumatic diseases.
    Arnett FC
    Hosp Pract (Off Ed); 1986 Dec; 21(12):89-100. PubMed ID: 3098761
    [No Abstract]   [Full Text] [Related]  

  • 11. Cost of illness in rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and systemic lupus erythematosus in Germany.
    Huscher D; Merkesdal S; Thiele K; Zeidler H; Schneider M; Zink A;
    Ann Rheum Dis; 2006 Sep; 65(9):1175-83. PubMed ID: 16540552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting adherence to therapy in rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis: a large cross-sectional study.
    Smolen JS; Gladman D; McNeil HP; Mease PJ; Sieper J; Hojnik M; Nurwakagari P; Weinman J
    RMD Open; 2019; 5(1):e000585. PubMed ID: 30713716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Rheumatic diseases in pregnancy].
    Märker-Hermann E; Bauer H; Gromnica-Ihle E
    Dtsch Med Wochenschr; 2008 Nov; 133(46):2410-4. PubMed ID: 18988134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rationale for and clinical development of anti-fractalkine antibody in rheumatic diseases.
    Muraoka S; Nishio J; Kuboi Y; Imai T; Nanki T
    Expert Opin Biol Ther; 2020 Nov; 20(11):1309-1319. PubMed ID: 32401060
    [No Abstract]   [Full Text] [Related]  

  • 15. Structural damage in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: traditional views, novel insights gained from TNF blockade, and concepts for the future.
    Schett G; Coates LC; Ash ZR; Finzel S; Conaghan PG
    Arthritis Res Ther; 2011 May; 13 Suppl 1(Suppl 1):S4. PubMed ID: 21624183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Gene expression in inflammatory rheumatic diseases].
    Grützkau A; Grün J; Häupl T; Burmester GR; Radbruch A
    Dtsch Med Wochenschr; 2007 Sep; 132(37):1888-91. PubMed ID: 17823881
    [No Abstract]   [Full Text] [Related]  

  • 17. The genetics of rheumatic disease in man.
    Goldstein R; Arnett FC
    Rheum Dis Clin North Am; 1987 Dec; 13(3):487-510. PubMed ID: 3324202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T cell subsets and their role in the pathogenesis of rheumatic disease.
    Gizinski AM; Fox DA
    Curr Opin Rheumatol; 2014 Mar; 26(2):204-10. PubMed ID: 24445478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blocking IL-17: A Promising Strategy in the Treatment of Systemic Rheumatic Diseases.
    Rafael-Vidal C; Pérez N; Altabás I; Garcia S; Pego-Reigosa JM
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32993066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical characteristics of patients with rheumatic diseases and abnormal liver function].
    Wu CY; Li MC; Duan XW; Li HB; Wang YH; Li Q; Luo H; Xu J; Wu LJ; Wang YF; Zhao C; Fang YF; Lin SD; Xu D; Tian XP; Li MT; Zeng XF
    Zhonghua Nei Ke Za Zhi; 2023 Sep; 62(9):1102-1113. PubMed ID: 37650184
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 23.